Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 17 | 2025 | 2147 | 3.030 |
Why?
|
| Brain | 6 | 2025 | 1554 | 1.170 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 644 | 1.150 |
Why?
|
| Gangliosidosis, GM1 | 2 | 2025 | 19 | 1.130 |
Why?
|
| Brain Ischemia | 3 | 2025 | 417 | 1.070 |
Why?
|
| Stroke | 2 | 2023 | 1190 | 0.830 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2025 | 84 | 0.820 |
Why?
|
| ErbB Receptors | 2 | 2013 | 114 | 0.750 |
Why?
|
| Glioma | 2 | 2013 | 100 | 0.730 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2178 | 0.680 |
Why?
|
| Intestines | 1 | 2021 | 166 | 0.660 |
Why?
|
| Intracranial Aneurysm | 2 | 2023 | 363 | 0.610 |
Why?
|
| Collagen | 1 | 2019 | 127 | 0.590 |
Why?
|
| Kyphosis | 1 | 2018 | 5 | 0.580 |
Why?
|
| Achondroplasia | 1 | 2018 | 2 | 0.580 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2018 | 5 | 0.580 |
Why?
|
| Tay-Sachs Disease | 3 | 2025 | 45 | 0.580 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 87 | 0.570 |
Why?
|
| Spine | 1 | 2018 | 48 | 0.560 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 67 | 0.560 |
Why?
|
| Blood Vessels | 1 | 2017 | 62 | 0.550 |
Why?
|
| Animals | 19 | 2025 | 20612 | 0.530 |
Why?
|
| Hydrogels | 1 | 2018 | 115 | 0.520 |
Why?
|
| Contrast Media | 3 | 2015 | 421 | 0.510 |
Why?
|
| Genetic Therapy | 5 | 2025 | 771 | 0.460 |
Why?
|
| Biomimetics | 1 | 2014 | 29 | 0.440 |
Why?
|
| Liposomes | 1 | 2014 | 106 | 0.430 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 65 | 0.430 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 75 | 0.420 |
Why?
|
| Neuroimaging | 2 | 2025 | 154 | 0.420 |
Why?
|
| Molecular Imaging | 1 | 2013 | 48 | 0.410 |
Why?
|
| Coordination Complexes | 1 | 2012 | 9 | 0.400 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 227 | 0.400 |
Why?
|
| Cerebral Angiography | 3 | 2023 | 290 | 0.390 |
Why?
|
| Manganese Compounds | 1 | 2012 | 8 | 0.380 |
Why?
|
| Peroxidase | 1 | 2012 | 71 | 0.380 |
Why?
|
| Chlorides | 1 | 2012 | 31 | 0.380 |
Why?
|
| Dogs | 3 | 2025 | 325 | 0.370 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 294 | 0.370 |
Why?
|
| Brain Neoplasms | 2 | 2013 | 308 | 0.360 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2025 | 667 | 0.360 |
Why?
|
| Tomography, Optical Coherence | 2 | 2024 | 223 | 0.350 |
Why?
|
| Humans | 23 | 2025 | 62866 | 0.310 |
Why?
|
| Disease Progression | 2 | 2025 | 1159 | 0.280 |
Why?
|
| Dependovirus | 5 | 2025 | 695 | 0.280 |
Why?
|
| White Matter | 2 | 2025 | 123 | 0.270 |
Why?
|
| Cerebrovascular Circulation | 2 | 2025 | 178 | 0.260 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2023 | 287 | 0.260 |
Why?
|
| Genetic Vectors | 4 | 2025 | 851 | 0.260 |
Why?
|
| Cattle | 2 | 2019 | 309 | 0.250 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2025 | 1 | 0.240 |
Why?
|
| Phenylketonurias | 1 | 2025 | 2 | 0.240 |
Why?
|
| Male | 12 | 2025 | 29546 | 0.240 |
Why?
|
| Gray Matter | 1 | 2025 | 35 | 0.240 |
Why?
|
| Respiration | 2 | 2017 | 89 | 0.240 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2025 | 18 | 0.240 |
Why?
|
| Phenylalanine | 1 | 2025 | 26 | 0.240 |
Why?
|
| Solubility | 2 | 2018 | 179 | 0.240 |
Why?
|
| Sandhoff Disease | 1 | 2025 | 35 | 0.240 |
Why?
|
| Female | 11 | 2025 | 32560 | 0.230 |
Why?
|
| Atrophy | 1 | 2025 | 83 | 0.230 |
Why?
|
| Mice | 8 | 2025 | 10815 | 0.230 |
Why?
|
| Neurofibromin 1 | 1 | 2024 | 14 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 622 | 0.220 |
Why?
|
| Rats | 3 | 2013 | 1980 | 0.220 |
Why?
|
| Neurofibromatosis 1 | 1 | 2024 | 32 | 0.220 |
Why?
|
| Codon, Nonsense | 1 | 2024 | 58 | 0.220 |
Why?
|
| Cerebral Arteries | 1 | 2024 | 40 | 0.220 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2017 | 207 | 0.210 |
Why?
|
| Mice, Inbred DBA | 2 | 2014 | 84 | 0.210 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2025 | 152 | 0.210 |
Why?
|
| Infant | 2 | 2025 | 1623 | 0.210 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2023 | 14 | 0.200 |
Why?
|
| Oligodendroglia | 2 | 2025 | 36 | 0.200 |
Why?
|
| Myelin Sheath | 2 | 2025 | 37 | 0.200 |
Why?
|
| Carotid Artery, Internal | 1 | 2023 | 68 | 0.200 |
Why?
|
| Models, Anatomic | 1 | 2023 | 65 | 0.200 |
Why?
|
| Rats, Nude | 2 | 2013 | 25 | 0.200 |
Why?
|
| Child, Preschool | 2 | 2025 | 1962 | 0.200 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 98 | 0.190 |
Why?
|
| Infarction | 1 | 2022 | 20 | 0.190 |
Why?
|
| Treatment Outcome | 2 | 2023 | 5598 | 0.190 |
Why?
|
| Rabbits | 1 | 2022 | 332 | 0.190 |
Why?
|
| Radial Artery | 1 | 2022 | 53 | 0.190 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1115 | 0.190 |
Why?
|
| Mutation | 3 | 2018 | 2598 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 1273 | 0.180 |
Why?
|
| Thrombectomy | 1 | 2023 | 227 | 0.180 |
Why?
|
| Demography | 1 | 2021 | 173 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 217 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 3387 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1454 | 0.170 |
Why?
|
| Oxygen | 1 | 2022 | 316 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 163 | 0.170 |
Why?
|
| Injections | 1 | 2020 | 81 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 95 | 0.160 |
Why?
|
| Thalamus | 1 | 2020 | 66 | 0.160 |
Why?
|
| Weight Loss | 1 | 2021 | 272 | 0.160 |
Why?
|
| Implants, Experimental | 1 | 2019 | 5 | 0.160 |
Why?
|
| Movement | 2 | 2017 | 155 | 0.150 |
Why?
|
| Stents | 1 | 2022 | 487 | 0.150 |
Why?
|
| Child | 2 | 2025 | 4478 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2017 | 477 | 0.150 |
Why?
|
| Myelin Basic Protein | 1 | 2018 | 21 | 0.140 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 25 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 866 | 0.140 |
Why?
|
| Diffusion | 1 | 2017 | 83 | 0.140 |
Why?
|
| Luciferases | 1 | 2018 | 109 | 0.140 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 120 | 0.140 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 90 | 0.140 |
Why?
|
| Adolescent | 2 | 2025 | 6197 | 0.140 |
Why?
|
| Chelating Agents | 2 | 2018 | 50 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2018 | 71 | 0.130 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2017 | 51 | 0.130 |
Why?
|
| Heart | 2 | 2017 | 282 | 0.130 |
Why?
|
| Photoacoustic Techniques | 1 | 2015 | 5 | 0.130 |
Why?
|
| Ferric Compounds | 1 | 2015 | 42 | 0.120 |
Why?
|
| Dextrans | 1 | 2015 | 46 | 0.120 |
Why?
|
| Survival Rate | 1 | 2018 | 843 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 718 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 672 | 0.120 |
Why?
|
| Young Adult | 1 | 2025 | 4656 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 97 | 0.110 |
Why?
|
| Manganese | 1 | 2014 | 24 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2023 | 6549 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 135 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2025 | 1640 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1194 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 208 | 0.110 |
Why?
|
| Gold | 1 | 2015 | 226 | 0.100 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2012 | 3 | 0.100 |
Why?
|
| Pentetic Acid | 1 | 2012 | 33 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2012 | 76 | 0.100 |
Why?
|
| Drug Stability | 1 | 2012 | 143 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 49 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 252 | 0.100 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 70 | 0.090 |
Why?
|
| Gadolinium | 1 | 2012 | 106 | 0.090 |
Why?
|
| Motion | 2 | 2025 | 59 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 325 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2012 | 293 | 0.090 |
Why?
|
| Horseradish Peroxidase | 1 | 2011 | 15 | 0.090 |
Why?
|
| Adult | 2 | 2025 | 16668 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 455 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 165 | 0.090 |
Why?
|
| Kinetics | 1 | 2012 | 764 | 0.090 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 87 | 0.090 |
Why?
|
| Time Factors | 1 | 2018 | 3749 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 229 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 863 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2015 | 517 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2011 | 191 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 233 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 734 | 0.070 |
Why?
|
| Red Nucleus | 1 | 2025 | 5 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 2025 | 34 | 0.060 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2025 | 13 | 0.060 |
Why?
|
| Abdomen | 2 | 2017 | 92 | 0.060 |
Why?
|
| Collateral Circulation | 1 | 2025 | 25 | 0.060 |
Why?
|
| Thalamic Nuclei | 1 | 2025 | 24 | 0.060 |
Why?
|
| Amygdala | 1 | 2025 | 83 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2025 | 42 | 0.060 |
Why?
|
| Artifacts | 2 | 2017 | 128 | 0.060 |
Why?
|
| Oxadiazoles | 1 | 2024 | 8 | 0.060 |
Why?
|
| Miniaturization | 1 | 2024 | 10 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 57 | 0.060 |
Why?
|
| Microscopy | 1 | 2024 | 91 | 0.050 |
Why?
|
| X-Rays | 1 | 2022 | 46 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2023 | 77 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2022 | 22 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 37 | 0.050 |
Why?
|
| Simvastatin | 1 | 2022 | 27 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 315 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 123 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 199 | 0.050 |
Why?
|
| Reflex | 1 | 2021 | 27 | 0.050 |
Why?
|
| Arginine | 1 | 2022 | 124 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2022 | 74 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 108 | 0.050 |
Why?
|
| Astrocytes | 1 | 2021 | 119 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 390 | 0.040 |
Why?
|
| Mammography | 1 | 2022 | 280 | 0.040 |
Why?
|
| Sheep | 1 | 2020 | 179 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 315 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 481 | 0.040 |
Why?
|
| Cuprizone | 1 | 2018 | 3 | 0.040 |
Why?
|
| Remyelination | 1 | 2018 | 3 | 0.040 |
Why?
|
| PPAR delta | 1 | 2018 | 10 | 0.040 |
Why?
|
| Quetiapine Fumarate | 1 | 2018 | 13 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 16 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2023 | 2104 | 0.030 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 8 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2017 | 33 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 186 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 919 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 224 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 66 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 302 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 76 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 186 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 1181 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1614 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1003 | 0.020 |
Why?
|